论文部分内容阅读
目的:评价莫西沙星注射液治疗老年肺部感染的临床疗效。方法:将92例老年中度(肺部感染)患者用莫西沙星静脉注射治疗,观察临床疗效、体温降至37.5℃时间、治疗6 d后Fine积分变化、显著好转所需时间、住院天数及不良反应等各项指标,分别与患者注射前比较。结果:治疗组体温降至37.5℃时间、治疗10 d后Fine积分变化、显著好转所需时间、住院天数等均明显好于对照组(P<0.05)。两者不良反应发生率无统计学差异(P>0.05)。结论:莫西沙星治疗老年肺部感染能明显缓解症状,提高疗效,安全性高。
Objective: To evaluate the clinical efficacy of moxifloxacin injection in the treatment of senile pulmonary infection. Methods: Ninety-two elderly patients with moderate pulmonary infection were treated with moxifloxacin intravenously. The clinical effects were observed. The body temperature was lowered to 37.5 ℃. The changes of the fine score, the time required for significant improvement, the length of hospital stay, Adverse reactions and other indicators, respectively, compared with the patients before injection. Results: The body temperature of the treatment group decreased to 37.5 ° C, the changes of the Fine integral after 10 days of treatment, the time required for significant improvement and the length of stay in the treatment group were significantly better than those in the control group (P <0.05). The incidence of adverse reactions between the two groups showed no significant difference (P> 0.05). Conclusion: Moxifloxacin in the treatment of senile pulmonary infection can relieve the symptoms and improve the curative effect and safety.